The Will Soliman Podcast

Prescription Drugs are Expensive. But Americans are paying more than they need to. On The Will Soliman Podcast , I sit down with Jason Cicardo, Founder and CEO of Discount RX Savings, to break down a resource millions of patients use but many still don’t fully understand: prescription discount cards. We discuss how these programs work, why the price of the same prescription can vary from pharmacy...

What happens when you put a self-proclaimed former “PBM Crime Boss” behind the mic? Jeremiah Shrack joins The Will Soliman Podcast for an insider conversation about one of the most powerful and least understood parts of American healthcare: Pharmacy Benefit Managers (PBMs). How do PBMs actually make money on prescription drugs? What’s buried inside complex PBM contracts? And why can employers and...

“This isn’t a lean-in situation. Women are leaning in. We did that already.” So where does biotech go from here? In this episode of The Will Soliman Podcast , William Soliman sits down with Dr. Joanne Kamens , CEO of Women in Bio , for a candid conversation about women, leadership, workplace culture, and why getting this right matters to biotech companies' performance. Kamens draws on a remark...

When did drug developers become the bad guys? Will Soliman sits down with Anna Rose Welch , Editor of Advancing RNA , for a candid discussion on what the public often gets wrong about biotechnology and the people developing tomorrow’s medicines. From RNA therapeutics and mRNA to gene editing, AI, precision medicine, regulation, reimbursement, and the race to bring new therapies to patients, Anna s...

The FDA is gathering industry input on the future of AI in clinical trials. In this episode, Genentech's  Nikheel Kolatkar ,  VP, Therapeutic Area Head, Medical Operations, US Medical, and  William Soliman   explored not only where AI is headed but also how organizations can implement it responsibly. The winners won’t be the companies with the most powerful AI. They’ll be the ones with the str...

Biogen’s Chief Medical Officer and Head of Medical Affairs, Dr. Daniel Quirk , joins William Soliman to unpack how a leading biotech is reshaping neuroscience, rare disease, and immunology in the era of AI. Listen to the end, as Daniel shares some career advice for medical students and aspiring medical science liaisons he's learned after 20 years. In this episode, they dive into: How  Biogen  ...

Primary care is at a crossroads. In this episode, Will Soliman sits down with the American Academy of Family Physicians President, Dr. Sarah Nosal, to discuss the most urgent issues shaping the future of family medicine and patient care. They examine the growing controversy surrounding non-science-based Hepatitis B vaccine recommendations, AI in prior authorizations, why evidence-based medicine mu...

In this episode of The Will Soliman Podcast, William Soliman sits down with Dr. Cristian Massacesi , high-energy Chief Medical Officer & Head of Drug Development at Bristol Myers Squibb (BMS) . They explore how AI is reshaping drug discovery and clinical development, from target validation to trial execution. Topics include: How AI is already accelerating drug discovery and clinical trials Why...

In this episode, Dr. William Soliman sits down with Dr. Michael Ybarra, Chief Medical Officer of PhRMA, the pharmaceutical industry's largest trade organization, for a candid conversation on drug pricing, healthcare policy, pharmaceutical innovation, patient access, and the future of medicine. Dr. Ybarra challenges some of the most common assumptions about prescription drug costs, explaining the r...

At just 22 years old, Rob Long was living the dream, preparing himself to be one of the nation’s top football prospects out of Syracuse University, when everything changed in an instant. After being diagnosed with a rare, incurable brain cancer and undergoing surgery that removed 25% of his brain, Rob was forced into a fight far bigger than football. What followed is a story of survival, resilienc...

What happens when artificial intelligence starts designing medicines faster than the pharmaceutical industry can comprehend? In this explosive conversation, Dr. Will Soliman sits down with Alex Zhavoronkov, CEO, one of the most provocative voices in AI drug discovery and the founder of Insilico Medicine, to discuss the future of medicine, longevity, biotech, and the AI arms race transforming pharm...

Are we losing the battle against preventable diseases? Watch Dr. Kelly Moore, CEO, and Dr. LJ Tan, Chief Policy Officer from Immunize.org, weigh in on “what is fact and myth”, along with Vaccine Committee Influencers, and what’s at risk for parents and children with Dr. Will Soliman. The Vaccine - Autism Myth to address the persistent misinformation regarding vaccines and autism. Hear from the exp...

For the first time, former pharmaceutical sales rep Allison Marie Zayas tells her story as a whistleblower. What she witnessed in the pharma industry was shocking: the patients caught in the middle and the fallout that followed. Hear how a top-performing sales rep risked it all to protect patients from the potential risk of death.